Your browser doesn't support javascript.
loading
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Bashari, Muhammad Hasan; Fan, Fengjuan; Vallet, Sonia; Sattler, Martin; Arn, Melissa; Luckner-Minden, Claudia; Schulze-Bergkamen, Henning; Zörnig, Inka; Marme, Frederik; Schneeweiss, Andreas; Cardone, Michael H; Opferman, Joseph T; Jäger, Dirk; Podar, Klaus.
Afiliação
  • Bashari MH; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Fan F; Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Jl. Eijkman 38, Bandung, 02215, Indonesia.
  • Vallet S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Sattler M; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Arn M; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
  • Luckner-Minden C; Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, USA.
  • Schulze-Bergkamen H; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Zörnig I; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Marme F; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Schneeweiss A; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Cardone MH; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Opferman JT; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, Heidelberg, 69120, Germany.
  • Podar K; Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, USA.
Breast Cancer Res ; 18(1): 26, 2016 Feb 26.
Article em En | MEDLINE | ID: mdl-26921175

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Hipóxia Celular / Receptor ErbB-2 / Proteína de Sequência 1 de Leucemia de Células Mieloides Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Hipóxia Celular / Receptor ErbB-2 / Proteína de Sequência 1 de Leucemia de Células Mieloides Idioma: En Ano de publicação: 2016 Tipo de documento: Article